Company intelligence / Profile preview
NovaBay Pharmaceuticals, Inc.
Emeryville, California, United Statesnovabay.com ↗
- Ownership
- Public · NBY
- Development stage
- Commercial
01
Overview
NovaBay's leading product Avenova is clinically proven to be effective for blepharitis and dry eye disease. The company has expanded its product portfolio with lubricating eye drops and recently introduced Avenova Allograft for eyecare professionals.
- Therapeutic areas
- OphthalmologyDermatology
- Modalities
- Small moleculesHypochlorous acid (HOCl)Aganocide compounds
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
03
Partnerships
Galderma (dermatology)BioStem Technologies (amniotic tissue allograft)PRN Physician Recommended Nutriceuticals LLC (pending sale of Avenova eyecare business)
Beyond the preview
Go deeper on NovaBay Pharmaceuticals, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NovaBay Pharmaceuticals, Inc..